Select Medical Holdings Corp (SEM) Stock Price & Analysis
Select Medical Holdings Corp (SEM) rose 0.36% to USD 16.63 as of June 10, 2026 at 02:36 UTC, according to Nexqual real-time market data.
SEM last closed at USD 16.57; the session ranged USD 16.59–16.68 on volume of 1,208,167 shares. Market capitalization is $2.06B, with a 52-week range of USD 11.65–16.99 (NYQ). Source: Nexqual, June 10, 2026 at 02:36 UTC.
Key Statistics (as of June 10, 2026 at 02:36 UTC)
| Price | USD 16.63 |
|---|---|
| Change | ▲ 0.36% (up) |
| Previous Close | USD 16.57 |
| Open | USD 16.59 |
| Day Range | USD 16.59 – 16.68 |
| 52-Week Range | USD 11.65 – 16.99 |
| Volume | 1,208,167 shares |
| Market Cap | $2.06B |
| Exchange | NYQ |
Technical Analysis (SEM)
Nexqual's technical model rates SEM "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 02:36 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 72.78 (overbought) |
| vs SMA50 | Above (USD 16.44) |
| MACD | 0.04 (positive) |
Analyst Ratings (SEM)
Wall Street analysts rate SEM "None" based on 4 analysts, with a mean price target of USD 16.63 (range USD 16.5–17), per Nexqual as of June 10, 2026 at 02:36 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 16.63 |
| High Target | USD 17 |
| Low Target | USD 16.5 |
| Buy / Hold / Sell | 1 / 4 / 0 |
Earnings (SEM)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.29 |
| Revenue Estimate | $1.40B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.36 vs est 0.46 ▼ miss |
| 2025-12-31 | USD 0.16 vs est 0.23 ▼ miss |
| 2025-09-30 | USD 0.23 vs est 0.15 ▲ beat |
| 2025-06-30 | USD 0.32 vs est 0.24 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Financials & Fundamentals (SEM)
| Total Revenue | $5.52B |
|---|---|
| Revenue Growth (YoY) | +5.00% |
| Gross Margin | +16.68% |
| Operating Margin | +6.92% |
| Profit Margin | +2.42% |
| ROE | +9.81% |
| Debt / Equity | 142.09 |
| Current Ratio | 1.15 |
| Total Cash | $25.68M |
| Total Debt | $2.99B |
| Free Cash Flow | $40.70M |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Financial Health Score (SEM)
Nexqual rates Select Medical Holdings Corp's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:36 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 17%, operating 7% |
| Balance Sheet | Mixed — $26M cash vs $2.99B debt |
| Cash Flow | Mixed — FCF $41M, slim 0.7% margin |
| Efficiency | Mixed — ROE 10%, ROA 3.4% |
Ownership (SEM)
| Insider Ownership | +15.95% |
|---|---|
| Institutional Ownership | +82.63% |
| Shares Outstanding | 124.01M |
| Float | 97.34M |
| Short % of Float | +3.32% |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
Leadership (SEM)
Select Medical Holdings Corp is led by Thomas P. Mullin (age 41), Chief Executive Officer, per Nexqual as of June 10, 2026 at 02:36 UTC.
| Chief Executive Officer | Thomas P. Mullin (age 41) |
|---|---|
| Co-Founder & Executive Chairman | Robert A. Ortenzio (age 67) |
| President | John A. Saich (age 56) |
| Executive VP & CFO | Michael F. Malatesta (age 55) |
| Senior Executive Vice President of Strategic Finance & Operations | Martin F. Jackson (age 70) |
Major Backers & Investors (SEM)
Notable institutional backers of Select Medical Holdings Corp include FIL LTD, Glazer Capital LLC, Goldman Sachs, according to Nexqual as of June 10, 2026 at 02:36 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FIL LTD | 4% |
| Glazer Capital LLC | 3.29% |
| Goldman Sachs | 1.68% |
| NexPoint Funds I-NexPoint Merger Arbitrage Fund | 0.99% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 22.22% |
| Vanguard Group | 16.25% |
| Dimensional Fund Advisors | 4.47% |
| State Street | 3.49% |
| Geode Capital | 2.15% |
| HSBC Holdings PLC | 1.81% |
Source: Nexqual, June 10, 2026 at 02:36 UTC.
From Select Medical Holdings Corp's Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.
- The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.
- The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer.
- The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| USPH | U.S. Physical Therapy, Inc. | USD 61.8 | ▼ 2.6% |
| MD | Pediatrix Medical Group, Inc. | USD 23.66 | ▲ 4.64% |
| EHC | Encompass Health Corporation | USD 104.19 | ▲ 0.17% |
| SGRY | Surgery Partners, Inc. | USD 13.96 | ▲ 1.82% |
| ENSG | The Ensign Group, Inc. | USD 155.25 | ▼ 8.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:36 UTC. This page is informational and not investment advice.